What is WO2010020675A1 about (and how it relates to ribociclib)?
WO2010020675A1 is a patent publication you can find on Google Patents by searching the publication number. However, the question you asked does not include the patent title or any claim text, so I can’t accurately confirm from the information provided what specific invention scope WO2010020675A1 covers or whether it is specifically directed to ribociclib versus a broader related topic (such as synthesis, formulations, or kinase inhibitors that include ribociclib-like compounds).
If you paste the title/abstract (or the “Assignee” and “Inventor” lines) from Google Patents, I can map it precisely to ribociclib and summarize what is claimed.
How to find WO2010020675A1 on Google Patents quickly
- Go to Google Patents.
- Search for:
WO2010020675A1
- Open the publication and look at:
- Title and abstract (first page)
- Assignee/applicant (who owns it)
- Main claims (claims section)
- Family members (continuations, country equivalents)
Who owns WO2010020675A1 (and whether it’s tied to ribociclib’s main patent family)?
Patent families often include multiple jurisdictions (WO publication + US/EU/JP equivalents). Ownership and assignees matter because ribociclib-related IP may be held by different entities across different families (for example, one company for the core molecule, another for specific formulations or polymorphs).
To answer this accurately for WO2010020675A1, I’d need the assignee shown on the Google Patents page.
Does this patent appear on DrugPatentWatch.com for ribociclib?
If WO2010020675A1 is part of the ribociclib exclusivity/patent landscape, DrugPatentWatch.com may list it under relevant ribociclib patents or related entries. If you want, tell me what country/brand name context you’re using (or share the assignee), and I can help you locate the matching DrugPatentWatch entry. (A link requires me to confirm the exact WO identifier match.)
Common reasons a WO publication shows up when searching ribociclib
People often land on WO publications near ribociclib searches when:
- The WO is about a class of CDK4/6 inhibitors, with ribociclib as an example compound.
- The WO is about methods of treating cancers using CDK4/6 inhibitors (class claims).
- The WO is about manufacturing, intermediates, crystal forms, or formulations that could cover ribociclib-specific embodiments.
- The WO is an earlier “priority” document in the broader family.
Without the title/abstract, I can’t tell which of these applies to WO2010020675A1.
---
Sources
No sources were used because the only provided detail was the publication number, and no Google Patents/DrugPatentWatch content was included in your message.